OSTEOGENESIS IMPERFECTA TYPE IV: A NEWLY IDENTIFIED VARIANT AT POSITION C.560 (G T; P.GLY187VAL) IN THE COL1A2 GENE

Osteogenesis imperfecta Type IV: a newly identified variant at position c.560 (G T; p.Gly187Val) in the COL1A2 gene

Osteogenesis imperfecta is a clinically heterogenous disease caused by defective collagen syntesis associated with a mutation in the COL1A1 or COL1A2 genes.In this report, we present a case of osteogenesis imperfecta (OI) type IV, seen in Cooking Ingredients a female fetus with incurved femurs at 18 weeks of gestation.Molecular analysis of the newb

read more

Optimization of a novel lead-free MASiI3 based perovskite solar cell: A comprehensive study on device performance enhancement

Methylammonium Silicon Iodide (MASiI3), a novel perovskite material, has recently Horse Halters garnered significant attention for its potential to enhance the stability of solar cells.However, MASiI3-based perovskite solar cells (PSCs) have yet to achieve high performance.In this study, we utilized SCAPS-1D device modeling to investigate and optim

read more


Role of traditional medicines in the management of cancer

Context: Increasing numbers of cancer patients are looking towards traditional medicines (TM) in an effort to sustain tumour remission or halt the metastasis.TM such as Chinese Traditional Medicines, Ayurveda and Unani Medicines are being used in many parts of world from centuries.However, scientific data is lacking for the clinical use of majority

read more

Has vaccination alleviated the strain on hospitals due to COVID-19? A combined difference-in-difference and simulation approach

Abstract Background Serious measures, including mass vaccination, have been taken to ensure sufficient hospital capacity during the COVID-19 pandemic.Due to high hospitalization risk in the oldest age groups, most countries prioritized elderly for vaccines.The aim of this study is to broaden the understanding of how vaccination in younger age group

read more